Bioasis Technologies Stock Today
| BIOAF Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
BiOasis Technologies is trading at 1.0E-4 as of the 26th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. BiOasis Technologies has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for biOasis Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut. The company has 79.41 M outstanding shares. More on biOasis Technologies
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BiOasis Pink Sheet Highlights
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
biOasis Technologies [BIOAF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BiOasis Technologies's market, we take the total number of its shares issued and multiply it by BiOasis Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. biOasis Technologies classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 79.41 M outstanding shares.
biOasis Technologies has accumulated about 764.97 K in cash with (3.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BiOasis Technologies Probability Of Bankruptcy
Ownership AllocationBiOasis Technologies holds a total of 79.41 Million outstanding shares. Nearly 97.95 percent of BiOasis Technologies outstanding shares are held by general public with 2.05 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BiOasis Ownership Details
BiOasis Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BiOasis Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
BiOasis Technologies Corporate Management
| Kim Elton | Director Marketing | Profile | |
| Mei Tian | VP Research | Profile | |
| Graeme Dick | Director Relations | Profile | |
| Doug MBA | Exec Officer | Profile | |
| Dave Jenkins | Chief Officer | Profile | |
| B FTSE | CEO Chairman | Profile |
Other Information on Investing in BiOasis Pink Sheet
BiOasis Technologies financial ratios help investors to determine whether BiOasis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BiOasis with respect to the benefits of owning BiOasis Technologies security.